Announced
Synopsis
Viveo, a Brazilian medicines and drugs wholesaler, agreed to acquire Proinfusion, a firm which offers hospitals and healthcare companies solutions for cancer treatment, for $50m. The transaction still requires approval from Brazil's antitrust watchdog."The transaction will allow Viveo to consolidate a manipulation platform assuring Viveo strategy's to enhance the rendering of services to hospitals, clinics and and health insurance companies.
Principals
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.